Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.53) per share.
Keybanc Maintains Overweight on Reliance Steel & Aluminum, Raises Price Target to $265
Keybanc analyst Philip Gibbs maintains Reliance Steel & Aluminum (NYSE:RS) with a Overweight and raises the price target from $235 to $265.